Phyton Biotech
Manufacturing · Canada · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1527 Cliveden Ave, Delta, British Columb...Phone Number
(604) 777-2340Website
www.phytonbiotech.comRevenue
$16.4 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Phyton Biotech
Phyton Biotech is the world's largest producer of taxane active pharmaceutical ingredients. The company produces Paclitaxel and Docetaxel through Plant Cell Fermentation (PCF(R)). These plant-derived products are used in the treatment of cancer and other life-threatening illnesses. Phyton was founded in 1990 in Ithaca, New York, and was acquired in 2003 by DFB Pharmaceuticals, a private Texas-based investment company. The company's manufacturing facilities are located in Ahrensburg, Germany and Delta, Canada.Explore more
Phyton Biotech Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Phyton Biotech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Phyton Biotech
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Phyton Biotech recently announced quarterly report
Website visits: Recent activity has been detected on your website
Phyton Biotech, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Phyton Biotech has new funding data
Check if Phyton Biotech has recently received funding, and reach out quickly before it becomes old news!
Click to see if Phyton Biotech had a recent Job posting/layoffs
Product Launch: Get notified when Phyton Biotech launches new products
Check out if Phyton Biotech is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Phyton Biotech as Masked Content
Find 3 more new buyers
Compare Similar Companies to Phyton Biotech
Compare insights from companies similar to Phyton Biotech, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Phyton Biotech is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Phyton Biotech is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Phyton Biotech.
Phyton Biotech Tech Stack
A closer look at the technologies used by Phyton Biotech
Phyton Biotech News & Media
Phyton Biotech gibt die erfolgreiche Entwicklung pflanzlicher Zelllinien als Quelle für einen Schlüsselbaustein zur Behandlung von seltenen Hautkrankheiten bekannt
FORT WORTH (Texas/USA)--(BUSINESS WIRE)--Phyton Biotech gab heute bekannt, dass das Unternehmen ertragreiche pflanzliche Zelllinien von Veratum californicum, der Quelle von Cyclopamin, entwickelt hat. Cyclopamin ist ein wichtiger Rohstoff für das topische Gel Patidegib von PellePharm, ein Prüfpräparat zur Behandlung seltener Hauterkrankungen. Dies ist der erste Schritt der Bemühungen, die Produktion von Cyclopamin aus erneuerbaren Quellen zu realisieren. Mit der proprietären Plant Cell FermentaPhyton Biotech Announces the Successful Establishment of Plant Cell Lines to Source Key Building Block for Treatment of Rare Dermatologic Conditions
FORT WORTH, Texas--(BUSINESS WIRE)--Phyton Biotech today announced that it has established high-yielding plant cell lines of Veratum californicum, the source of cyclopamine, a key raw material for PellePharm’s patedigib topical gel, an investigational treatment to be used for rare dermatologic conditions. This is the first step in efforts to enable the renewable production of cyclopamine. Through Phyton’s proprietary Plant Cell Fermentation (PCF®) technology, researchers successfully developedAqVida and Phyton Biotech Receive Approval from European Directorate of Quality Medicines for AqVida’s Cancer-fighting Paclitaxel Injectable Finished Dosage Formulation
FORT WORTH, Texas--(BUSINESS WIRE)--Phyton Biotech, a German/North American Plant Cell Fermentation (PCF®) technology company, and AqVida, a German oncology Finished Dosage Formulation (FDF) manufacturer, are pleased to announce today that they have received European approval from the EDQM (European Directorate of Quality Medicines) for AqVida’s paclitaxel injectable FDF. Phyton Biotech is the world’s leading manufacturer of paclitaxel active pharmaceutical ingredient (API), utilizing its prorpPhyton Biotech Partners with PellePharm to Develop Renewable Supply of Cyclopamine for Investigational Topical Cancer Therapy
FORT WORTH, Texas--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/biotech?src=hash" target="_blank"gt;#biotechlt;/agt;--Phyton Biotech and PellePharm today announced an exclusive partnership to develop a plant cell culture-based process to enable the future renewable production of the raw material for PellePharm’s patidegib, an investigational topical therapy for Gorlin Syndrome and High Frequency Basal Cell Carcinoma (BCC). PellePharm is currently investigating the safety and efficacy
Read more news
Top Manufacturing Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Phyton Biotech
Sign Up For FreeTo access detailed company insights
Phyton Biotech is the world's largest producer of taxane active pharmaceutical ingredients. The company produces Paclitaxel and Docetaxel through Plant Cell Fermentation (PCF(R)). These plant-derived products are used in the treatment of cancer and other life-threatening illnesses. Phyton was founded in 1990 in Ithaca, New York, and was acquired in... Read More
